19 December 2023 - The 21 serotypes covered by V116 are responsible for approximately 83% of invasive pneumococcal disease in ...
19 December 2023 - On the last day of November Texas launched extraordinary legal proceedings that could have wide-ranging political ...
12 December 2023 - Submission supported by positive results of a Phase 3 study showing immune response and safety in adults ...
6 December 2023 - As New Zealand’s response to the COVID-19 pandemic has evolved, so has ours. ...
1 December 2023 - The European Medicines Regulatory Network has been at the forefront of the fight against COVID-19 with ...
27 November 2023 - Exclusive Partner in Japan, Meiji Seika Pharma advances regulatory approval. ...
28 November 2023 - FDA fast track designation for bile duct cancer granted for CF33-hNIS (Vaxinia) MAST clinical program. ...
28 November 2023 - - Daiichi Sankyo today announced that Daichirona for intramuscular injection (DS-5670) for booster vaccination has been ...
27 November 2023 - Valneva today announced that the EMA has performed a technical validation of the marketing authorisation application ...
20 November 2023 - The Australian Government has accepted the latest advice from the Australian Technical Advisory Group on Immunisation on ...
9 November 2023 - Today, the US FDA approved Ixchiq, the first chikungunya vaccine. ...
1 November 2023 - After holding oversight roles for covid vaccines, two regulators from the US FDA went to work for ...
1 November 2023 - From today, the shingles vaccine Shingrix has replaced Zostavax on the National Immunisation Program schedule for ...
31 October 2023 - The EMA’s CHMP has recommended authorising an adapted Nuvaxovid vaccine targeting the Omicron XBB.1.5 subvariant of ...
25 October 2023 - Valneva today announces the submission of a marketing application with the EMA for approval of the ...